Sarepta Therapeutics Inc.

In News

Sarepta Therapeutics Inc (SRPT) (Q2 2026) Earnings Call Highlights: Strong Profitability and ... - Yahoo Finance

Yahoo Finance - Aug 06, 2026

Sarepta Therapeutics Navigates FDA Hold on Elevidys in Expanding DMD Market - Streetwise Reports

Streetwise Reports - Aug 06, 2026

Sarepta Therapeutics, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:SRPT) 2026-08-06 - Seeking Alpha

Seeking Alpha - Aug 06, 2026

Empowered Funds LLC Has $2.48 Million Stake in Sarepta Therapeutics, Inc. $SRPT - marketbeat.com

marketbeat.com - Aug 06, 2026

State Street (NYSE: STT) discloses 8.4% Sarepta Therapeutics ownership via Schedule 13G - Stock Titan

Stock Titan - Aug 07, 2026

Is Sarepta Therapeutics Inc (SRPT) a Value Opportunity After Q2 Loss? GF Score: 63/100, Revenue at $401.3M - GuruFocus

GuruFocus - Aug 06, 2026

Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Recent Corporate Developments - investorrelations.sarepta.com

investorrelations.sarepta.com - Feb 25, 2026

Sarepta Therapeutics Inc expected to post earnings of 26 cents a share - Earnings Preview - TradingView

TradingView - Aug 03, 2026

Sarepta Therapeutics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance

Yahoo Finance - Aug 06, 2026

Sarepta Therapeutics (NASDAQ: SRPT) swings to Q2 loss, details ELEVIDYS - Stock Titan

Stock Titan - Aug 05, 2026

Sarepta Therapeutics Q2 Earnings Call Highlights - marketbeat.com

marketbeat.com - Aug 06, 2026

Sarepta Therapeutics Announces First Quarter 2026 Financial Results and Recent Corporate Developments - investorrelations.sarepta.com

investorrelations.sarepta.com - May 06, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment